Thalidomide-NH-amido-PEG3-C2-NH2 Catalog No.:M14050-2 2) increased bioavailability of the

2) increased bioavailability of the normally short-lived antimetabolite TFT by preventing its degradation into the inactive form trifluorothymine (TF-Thy)

Selection and early clinical evaluation of the brain-penetrant 11β-hydroxysteroid dehydrogenase type 1 (11β-HSD1) inhibitor UE2343 (Xanamem™)

JTP-74057) (0

3*1-5(7)4-6(2)3/h2-4

solasodine and diosgenin (40 μM) show 66%

Thalidomide-NH-amido-PEG3-C2-NH2 Catalog No.:M14050-2 2) increased bioavailability of theThalidomide NH amido PEG3 C2 NH2 is a synthesized E3 ligase ligand linker conjugate that incorporates the Thalidomide based cereblon ligand and a linker used in PROTAC technology. Product information Molecular Weight: 505. 52 Formula: C23H31N5O8 Chemical Name: N (2 {2 [2 (2 aminoethoxy)ethoxy]ethoxy}ethyl) 2 {[2 (2,6 dioxopiperidin 3 yl) 1,3 dioxo 2,3 dihydro 1H isoindol 4 yl]amino}acetamide Smiles: